Consistent with our results, another small drug agonist of KRAS (which binds the GTP/GDP-binding pocket of KRAS and leads to the accumulation of GTP-KRAS) was previously reported to induce the apoptotic and autophagic cell death of lung cancer cells [52]. Here, KRAS is linked to lung carcinoma.